Stuart Finnie, PhD

Stuart Finnie, PhD, is a Senior Director and Group Manager within AstraZeneca’s CMC Regulatory Affairs Group, where he leads a team focused on synthetic products in oncology therapy. Stuart is a regulatory affairs professional with over 20 years of experience within the pharmaceutical industry. Working within the field of CMC, he has developed experience in both synthetic and biological molecules from development through life cycle management. He joined ISPE in 2021.